Atlas Trials

Tamoxifen in Duchenne Muscular Dystrophy

Clinical trial NCT03354039 · COMPLETED

Trial details

NCT number
NCT03354039
Sponsor
University Hospital, Basel, Switzerland
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Duchenne Muscular Dystrophy
Start date
2018-06-12
Primary completion
2022-07-25
Enrollment
93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.